Lactobacillus crispatus vaginal
Selected indexed studies
- Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. (Microb Cell Fact, 2020) [PMID:33160356]
- Lactobacillus crispatus dominant vaginal microbita in pregnancy. (Ceska Gynekol, 2020) [PMID:32414287]
- Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. (Benef Microbes, 2023) [PMID:36856121]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Lactobacillus crispatus dominant vaginal microbita in pregnancy. (2020) pubmed
- Impact of Lactobacillus crispatus-containing oral and vaginal probiotics on vaginal health: a randomised double-blind placebo controlled clinical trial. (2023) pubmed
- Orally administrated Lactobacillus gasseri TM13 and Lactobacillus crispatus LG55 can restore the vaginal health of patients recovering from bacterial vaginosis. (2023) pubmed
- Effectiveness of vaginal probiotics Lactobacillus crispatus chen-01 in women with high-risk HPV infection: a prospective controlled pilot study. (2024) pubmed
- Vaginal Lactobacillus fatty acid response mechanisms reveal a metabolite-targeted strategy for bacterial vaginosis treatment. (2024) pubmed
- Lactobacillus crispatus as biomarker of the healthy vaginal tract. (2016) pubmed
- Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial. (2025) pubmed
- Contribution of Lactobacillus iners to Vaginal Health and Diseases: A Systematic Review. (2021) pubmed
- Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health. (2020) pubmed
- DADA2: High-resolution sample inference from Illumina amplicon data. (2016) pubmed